BIO - Bio-Rad Laboratories, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
2,288,583
2,290,109
2,160,153
2,068,172
2,019,441
Cost of Revenue
1,049,771
1,065,747
972,754
930,085
897,771
Gross Profit
1,238,812
1,224,362
1,187,399
1,138,087
1,121,670
Operating Expenses
Research Development
200,016
199,196
250,301
205,864
192,972
Selling General and Administrative
824,066
833,294
808,942
816,724
761,990
Total Operating Expenses
1,024,082
1,032,490
1,059,243
1,022,588
954,962
Operating Income or Loss
214,730
191,872
128,156
115,499
166,708
Interest Expense
24,030
23,962
21,914
21,942
21,692
Total Other Income/Expenses Net
983,469
339,449
-8,437
-51,997
831
Income Before Tax
1,205,751
507,359
97,805
41,560
145,847
Income Tax Expense
300,949
146,363
-16,935
13,435
32,754
Income from Continuing Operations
904,802
360,996
114,740
28,125
113,093
Net Income
904,802
360,996
114,740
28,125
113,093
Net Income available to common shareholders
904,802
360,996
114,740
28,125
113,093
Reported EPS
Basic
-
12.10
3.87
0.96
3.87
Diluted
-
11.94
3.82
0.95
3.85
Weighted average shares outstanding
Basic
-
29,836
29,655
29,440
29,186
Diluted
-
30,228
30,034
29,646
29,409
EBITDA
-
669,409
268,401
206,399
299,387